5'-Phosphonate modified oligoadenylates as potent activators of human RNase L

Bioorg Med Chem. 2022 Feb 15:56:116632. doi: 10.1016/j.bmc.2022.116632. Epub 2022 Jan 19.

Abstract

The oligoadenylate synthetase-ribonuclease L pathway is a major player in the interferon-induced antiviral defense mechanism of cells. Upon sensing viral dsRNA, 5'-phosphorylated 2',5'-oligoadenylates are synthesized, and subsequently activate latent RNase L. To determine the influence of 5'-phosphate end on the activation of human RNase L, four sets of 5'-phosphonate modified oligoadenylates were prepared on solid-phase. The ability of these 5'-modified oligoadenylates bearing shortened, isosteric and prolonged phosphonate linkages to activate RNase L was explored. We found that isosteric linkages and linkages prolonged by one atom were in general well tolerated by the enzyme with the EC50 values comparable to that of the natural activator. In contrast, linkages shortened by one atom or prolonged by two atoms exhibited decrease in the activity.

Keywords: 2-5A; OAS-RNase L pathway; Oligoadenylate; Phosphonate oligonucleotide; RNase L.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenine Nucleotides / chemical synthesis
  • Adenine Nucleotides / chemistry
  • Adenine Nucleotides / pharmacology*
  • Dose-Response Relationship, Drug
  • Endoribonucleases / metabolism*
  • Humans
  • Nucleic Acid Conformation
  • Oligoribonucleotides / chemical synthesis
  • Oligoribonucleotides / chemistry
  • Oligoribonucleotides / pharmacology*
  • Organophosphonates / chemical synthesis
  • Organophosphonates / chemistry
  • Organophosphonates / pharmacology*
  • Structure-Activity Relationship

Substances

  • Adenine Nucleotides
  • Oligoribonucleotides
  • Organophosphonates
  • 2',5'-oligoadenylate
  • Endoribonucleases
  • 2-5A-dependent ribonuclease